# ScoreItem: Massa apendicular (kg)

**ID:** `019bf31d-2ef0-7e12-9247-4e29ce1e7185`
**FullName:** Massa apendicular (kg) (Composi√ß√£o corporal - Atual - Medidas objetivas)

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 12 artigos
- Avg Similarity: 0.523

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7e12-9247-4e29ce1e7185`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7e12-9247-4e29ce1e7185",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 0,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Nota:** `points` deve ser `0` neste item ‚Äî n√£o calcule pontua√ß√£o.

---

### Contexto Cient√≠fico

**ScoreItem:** Massa apendicular (kg) (Composi√ß√£o corporal - Atual - Medidas objetivas)

**30 chunks de 12 artigos (avg similarity: 0.523)**

### Chunk 1/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.601

otrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChinesepopulation.Wepreviouslypub-lishedarelevantarticle[16].ManystudiesshowedthatvitaminDwascloselyrelatedtomusclesandbones.Notably,ourresultsshowedthatexcludingtheinfluenceofvitaminD,oxytocinwasalsoassociatedwithosteo-porosis,andfollistatinandDHEAwereassociatedwithsarcopenia.Inourstudy,milkconsumption(<50mL/dayvs.‚â•250mL/day)(OR6.32;95%CI1.04‚Äì38.29;p=0.045)wasassociatedwithsarcopenia.Thereasonisthatmilkcontainsnutrients,especiallywheyprotein,thatmaybemyoprotective.Onetrialinvestigatedtheeffectofaddingmilkproteintothehabitualdietonskeletalmusclemass,strength,andphysicalperformanceinMexicanelderlyindividualswithoutsarcopenia.Theresultsshowedthatconsumptionmayreducetheriskofsarco-peniabyimprovingskeletalmusclemassduetotheadditionofnutrient-richdairyproteinstothehabitualdiet[36].However,curr

---

### Chunk 2/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.577

rcopeniawasbasedonappendicularskeletalmusclemass(ASM;kg)measurementsandwasnormalizedforheight[ASMI(AppendicularSkeletalMuscleMassIndex)=ASM/height2(kg/m2)].SarcopeniawasdefinedasmeetingtheAWGScriteria[18]andcategorizedusingthefollowingthresholdvalues:(1)LowmusclemasswasASMI<5.4kg/m2;(2)Lowmusclestrengthwashandgripstrength<18kg;and(3)Poorphysicalperformancewasgaitspeeds<0.8m/sbya6-mwalktest.AccordingtotheWorldHealthOrganization(WHO)definition[15],osteoporosiswasdefinedasaT-scoreofBMD‚â§‚àí2.5forvertebral,femurneckortotalhip,havingexperiencedalow-traumahiporvertebralfracture,orhavingosteopeniabyBMDwhosustainedalow-traumaproximalhumerus,pelvis,ordistalforearmfracture.Osteosarcopeniaisthecombinationofsarcope-niaandosteoporosis.LaboratoryanalysesSerumsampleswerecollectedbetween0700and0900haftera10-hfast,andfreshlyseparatedserumwasdi-videdinto0.5-mlaliquotsandstoredat‚àí80¬∞C.Serumlevelsoffollistatin,myostatin,BDNFandoxytocinweremeasuredusingQuantikineELISA(R&DSystems,Min-neapolis,MN,USA),wi

---

### Chunk 3/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.551

I:Appendicularskeletalmassindex;AWGS:AsianWorkingGroupforSarcopenia;BDNF:Brain-derivedneurotrophicfactor;BMD:Bonemineraldensity;BMI:Bodymassindex;CI:Confidenceintervals;COPD:Chronicobstructivepulmonarydisease;CT:Computedtomography;CTX:C-telopeptidecollagencrosslinks;CV:Coefficientsofvariance;DHEA:Dehydroepiandrosterone;DXA:DualenergyX-rayabsorptiometry;E2:Estradiol;FSH:Folliclestimulatinghormone;LH:Luteinizinghormone;MRI:Magneticresonanceimaging;OR:Oddsratios;P1NP:N-terminalpropeptideoftype1collagen;PTH:Parathyroidhormone;SHBG:Sexhormone-bindingglobulin;SPPB:Shortphysicalperformancebattery;T2:Testosterone;TGF-Œ≤:Transforminggrowthfactor-beta;WHO:WorldHealthOrganization
Table4Correlationofhistoryoffragilefracture,lifestyleandserumbiomarkerswithosteoporosisorsarcopeniabyLogisticRegressionVariablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24 

---

### Chunk 4/30
**Article:** Bases Metab√≥licas das Doen√ßas Cr√¥nicas e Gerenciamento - Inflama√ß√£o 1 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.547

inflama√ß√£o prejudica o anabolismo e, em contrapartida, a perda de massa remove um tamp√£o anti-inflamat√≥rio (mioquinas), piorando o cen√°rio metab√≥lico. Em sua forma mais estrat√©gica, torna‚Äëse eixo terap√™utico: construir/preservar massa muscular passa a ser interven√ß√£o anti-inflamat√≥ria de base, conectando nutri√ß√£o proteica, exerc√≠cio e controle de RI. Ele se integra naturalmente com ‚Äúmioquinas como reguladores‚Äù e com ‚Äúobesidade sarcop√™nica‚Äù como est√°gio avan√ßado do mesmo continuum inflamat√≥rio.
**Trilha de evid√™ncias:**
> ‚ÄúA sarcopenia... come√ßa j√° na juventude, quando a pessoa n√£o faz exerc√≠cio... Low-grade inflammation... prejudica a muscle protein synthesis... aumento da quebra...‚Äù
>
> ‚Äúobeso sarcop√™nico... 40% maior mortalidade.‚Äù
>
> ‚ÄúAs mioquinas exercem um papel regulador...

---

### Chunk 5/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIX (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.546

g/kg) e pr√°tica de exerc√≠cios de resist√™ncia para preservar massa muscular.
- [ ] 3. Todos os profissionais: Em doen√ßas cr√¥nicas sem causa org√¢nica clara ou com m√° resposta ao tratamento, investigar ativamente traumas de inf√¢ncia, estresse cr√¥nico e quest√µes emocionais n√£o resolvidas como poss√≠vel "causa primeira".
- [ ] 4. Terapeutas e psic√≥logos: Adotar "terapia de precis√£o", utilizando m√∫ltiplas ferramentas e combinando diferentes abordagens terap√™uticas para personalizar o tratamento e focar em resultados mensur√°veis, em vez de seguir uma √∫nica linha te√≥rica por longos per√≠odos.
- [ ] 5. Estudo pessoal: Pesquisar o conceito de "causa primeira" de Arist√≥teles para aprofundar a l√≥gica de buscar a origem dos problemas.
- [ ] 6. Estudo pessoal: Ler o livro de Bruce Lipton sobre a conex√£o entre mente e doen√ßas f√≠sicas.

---

## SOAP

> Data e Hora: 2025-11-17 16:33:53
> Paciente: 
> Diagn√≥stico:

## Hist√≥rico do Diagn√≥stico:
1. Hist√≥rico M√©dico: 
2.

---

### Chunk 6/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.546

rethanonefracture.Toanalyzethechangesinvariousindicatorswithaging,subjectsweredividedintothreegroups:age65,65‚â§age<75,and75‚â§age.Gripstrength,gaitspeed,serumlevelsofDHEA,oxytocin,BMDoffemoralneckandtotalhip,andleanmassdecreasedsignificantlywithaging.Historyoffragil-ityfractureandserumlevelofT2increasedsignificantlywithage.Withincreasingage,theamountofphysicalexerciseandmilkconsumptiondecreasedsignificantly.Associationofserumbiomarkerswithbonemass,musclemassormusclestrengthadjustedforageStepwisemultivariatelinearregressionwasperformedtoassessthecorrelationbetweenbiomarkersandbonemass,musclemassandstrengthadjustedforage.TheresultsshowedthatDHEAwaspositivelyrelatedtohandgrip(Œ≤=0.403,p=0.041)andgaitspeed(Œ≤=0.58,p=0.004).Follistatin(Œ≤=‚àí0.28,p=0.01)wasnegativelyrelatedtoleanmass,andoxytocin(Œ≤=0.35,p=0.036)waspositivelyrelatedtoleanmass.Myostatin(Œ≤=0.92,p=0.021)waspositivelyrelatedtofatmass.Myostatin(Œ≤=‚àí0.31,p=0.032)andfollistatin(Œ≤=‚àí0.48,p=0.042)werenegativelyassociatedwithASM

---

### Chunk 7/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.541

composition with metabolism and disease. J Nutr Health Aging 2005;9:408‚Äì419
86. Berkman LF, Seeman TE, Albert M et al. High, usual and impaired functioning in
community-dwelling older men and women: Findings from the MacArthur Foundation
Research Network on Successful Aging. 
J Clin Epidemiol 1993;46:1129‚Äì1140
87. Morrison MF, Katz IR, Parmelee P et al. 
Dehydroepiandrosterone sulfate (DHEA-S) and
psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr
Psychiatry 1998;6:277‚Äì284
88. Abbasi A, Duthie EH, Sheldahl L et al. Association of dehydroepiandrosterone sulfate,
body composition, and physical fitness in independent communitydwelling older men and
women. J Am Geriatr Soc 1998;46:263‚Äì273
89. Clarke BL, Ebeling PR, Jones JD, Wahner HW, O‚ÄôFallon WM, Riggs BL, Fitzpatrick LA.
Predictors of bone mineraldensity in aging healthy men varies by skeletal site. Calcified Tiss
Int 2002;70:137‚Äì145
90.

---

### Chunk 8/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.539

BDNF(ng/ml)22.67¬±13.330.75¬±10.628.74¬±7.830.80¬±10.90.265Oxytocin(pg/ml)398.3(173.2‚Äì662.6)425.8(200.2‚Äì702.3)500.4(289.3‚Äì823.4)612.7(356.2‚Äì1276.5)0.022BMD(g/cm2)LumbarSpine0.703¬±0.150.695¬±0.060.895¬±0.090.886¬±0.08<0.001FemoralNeck0.579¬±0.090.612¬±0.100.648¬±0.060.659¬±0.100.019TotalHip0.722¬±0.100.748¬±0.110.767¬±0.090.816¬±0.130.007BMI(kg/m2)19.41¬±1.923.96¬±3.320.31¬±1.925.09¬±2.6<0.001Fatmass(kg)15.50¬±2.320.86¬±4.918.59¬±5.121.43¬±4.00.001Leanmass(kg)30.43¬±2.436.99¬±3.832.87¬±3.138.27¬±3.8<0.001ASMI(kg/m2)4.92¬±0.26.22¬±0.54.96¬±0.36.44¬±0.5<0.001OSOsteosarcopenia,OPOsteoporosis,SPSarcopenia,NonSP/NonOPNosarcopenianoosteoporosis,DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagencrosslinks,P1NPN-terminalpropeptideoftype1collagen,BDNFBrain-derivedneurotrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChi

---

### Chunk 9/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.537

ResClinPract.2017;11(2):177‚Äì87.https://doi.org/10.1016/j.orcp.2016.04.003.4.PicettiD,FosterS,PangleAK,SchraderA,GeorgeM,WeiJY,etal.Hydrationhealthliteracyintheelderly.NutrHealthyAging.2017;4(3):227‚Äì37.https://doi.org/10.3233/NHA-170026.5.CurcioF,FerroG,BasileC,LiguoriI,ParrellaP,PirozziF,etal.Biomarkersinsarcopenia:amultifactorialapproach.ExpGerontol.2016;85:1‚Äì8.https://doi.org/10.1016/j.exger.2016.09.007.6.EastellR,SzulcP.Useofboneturnovermarkersinpostmenopausalosteoporosis.LancetDiabetesEndocrinol.2017;5(11):908‚Äì23.https://doi.org/10.1016/S2213-8587(17)30184-5.7.McPherronAC,LawlerAM,LeeSJ.RegulationofskeletalmusclemassinmicebyanewTGF-betasuperfamilymember.Nature.1997;387:83‚Äì90.8.FifeE,KostkaJ,Kroc≈Å,GuligowskaA,Pig≈ÇowskaM,So≈ÇtysikB,etal.Relationshipofmusclefunctiontocirculatingmyostatin,follistatinandGDF11inolderwomenandmen.BMCGeriatr.2018;18(1):200.https://doi.org/10.1186/s12877-018-0888-y.9.ChoiK,JangHY,AhnJM,HwangSH,ChungJW,ChoiYS,etal.Theassociationoftheserumlevelsofm

---

### Chunk 10/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.537

atmayleadtoahighesti-matedriskoffracturesandalowqualityoflifeintheelderlypopulation[1].Approximately212millionpeoplewillsufferfromosteoporosis,andthetotalnumberofhipfracturesisforecasttoreach3.25millioninChinaby2050[2].Becauseoftheseverityoftheconsequences,earlyscreeninganddiagnosis,preventionandinterven-tionforosteoporosisandtheriskoffractureareofgreatimportance.However,theclinicaldiagnosisishamperedbythreekeydifficultiesintheevaluationofmuscleandbonesta-tus.First,dual-energyX-rayabsorptiometry(DXA),magneticresonanceimaging(MRI)andcomputedtom-ography(CT)imagingmodalitiesprovideanobjectiveandsufficientlyreliableestimationofbodycomposition[3].However,theseimagingtechniquesaretechnically
¬©TheAuthor(s).2021OpenAccessThisarticleislicensedunderaCreativeCommonsAttribution4.0InternationalLicense,whichpermitsuse,sharing,adaptation,distributionandreproductioninanymediumorformat,aslongasyougiveappropriatecredittotheoriginalauthor(s)andthesource,providealinktotheCreativeCommonslicence,andindicat

---

### Chunk 11/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.537

rg/10.1111/joim.12369.16.ChengQ,DuY,HongW,TangW,LiH,ChenM,etal.Factorsassociatedtoserum25-hydroxyvitaminDlevelsamongolderadultpopulationsinurbanandsuburbancommunitiesinShanghai,China.BMCGeriatrics.2017;17(1):246.https://doi.org/10.1186/s12877-017-0632-z.17.Chinesenutritionsociety.Expertconsensusonnutritionandexercisemanagementinpatientswithprimaryosteoporosis.ChineseJEndocrinolMetab.2020;36(8):643‚Äì53.18.ChenL,LiuL,WooJ,etal.SarcopeniainAsia:consensusreportoftheAsianworkingGroupforSarcopenia.JAmMedDirAssoc.2014;15(2):95‚Äì101.https://doi.org/10.1016/j.jamda.2013.11.025.19.LiawF,KaoT,FangW,etal.Increasedfollistatinassociatedwithdecreasedgaitspeedamongoldadults.EurJClinInvestig.2016;46(4):321‚Äì7.https://doi.org/10.1111/eci.12595.20.IskenderianA,LiuN,DengQ,etal.Myostatinandactivinblockadebyengineeredfollistatinresultsinhypertrophyandimprovesdystrophicpathologyinmdxmousemorethanmyostatinblockadealone.SkeletMuscle.2018;8(1):34.21.ConsittLA,ClarkBC.TheviciouscycleofMyostatinsignalinginSarc

---

### Chunk 12/30
**Article:** Exercise as medicine ‚Äì evidence for prescribing exercise as therapy in 26 different chronic diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.525

tricindicators
andhipfracture.TheNHANESIepidemiologicfollow-upstudy.JAmGeriatrSoc1989:37:9‚Äì16.FarrellSW,FinleyCE,GrundySM.CardiorespiratoryÔ¨Åtness,LDLcholesterol,andCHDmortalityinmen.MedSciSportsExerc2012:44:
2132‚Äì2137.FaulknerG,CohnT,RemingtonG.Validationofaphysicalactivityassessmenttoolforindividualswith
schizophrenia.SchizophrRes2006:
82:225‚Äì231.FebbraioMA,PedersenBK.Muscle-derivedinterleukin-6:mechanisms
foractivationandpossiblebiologicalroles.FASEBJ2002:16:1335‚Äì1347.FelsonDT,NaimarkA,AndersonJ,KazisL,CastelliW,MeenanRF.Theprevalenceofkneeosteoarthritisintheelderly.TheFramingham
OsteoarthritisStudy.Arthritis
Rheum1987:30:914‚Äì918.FillitH,NashDT,RundekT,ZuckermanA.Cardiovascularrisk
factorsanddementia.AmJGeriatrPharmacother2008:6:100‚Äì118.FirthJ,CotterJ,ElliottR,FrenchP,YungAR.Asystematicreviewand
meta-analysisofexerciseinterventionsinschizophreniapatients.PsycholMed2015:45:
1343‚Äì1361.FitzgeraldGK,PivaSR,IrrgangJJ,BouzubarF,StarzTW.Quadricepsactivationfailureasamoderato

---

### Chunk 13/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.524

walkedatnormalcomfortablewalkingspeed.Ahand-heldtimerwasstartedwhenthesubjectedliftedonefoot,anditwasstoppedwhenoneofthesubjects‚Äôfeetstruckthegroundcompletelybeyondthefinishline.Thisprocesswasperformedtwiceconsecutivelywithoutrest,andthefasterofthe2timeswasusedfordataana-lysis.Subjectswereallowedtousetheirusualwalkingaids.Gaitspeedwascalculatedbydividing6mbythetimeinsecondsrequiredtocompletethecourse.BMDandbodycompositionmeasurementsBMDandbodycompositionweremeasuredusingdual-energyX-rayabsorptiometry(DXA;HologicDelphiA;HologicInc.,Waltham,MA,USA).Thesametechnicianperformedallscansandanalyses.Thecoefficientsofvariance(CVs)were0.86,1.86and0.95%forBMDofthelumbarspine,femurneckandtotalhip,respectively.Theinstrumentwascalibrateddailywithastandardphantom.DefinitionofsarcopeniaandosteoporosisSarcopeniawasbasedonappendicularskeletalmusclemass(ASM;kg)measurementsandwasnormalizedforheight[ASMI(AppendicularSkeletalMuscleMassIndex)=ASM/height2(kg/m2)].SarcopeniawasdefinedasmeetingtheAWGScriteria

---

### Chunk 14/30
**Article:** Gen√©tica e Epigen√©tica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.519

ualizados: definir faixas de FC, escolher modalidades (for√ßa/resist√™ncia) que promovam remodelamento muscular e biog√™nese mitocondrial; ajustar conforme nutri√ß√£o e status hormonal.
- [ ] 7. Desenvolver estrat√©gias alternativas de est√≠mulo √† biog√™nese mitocondrial para idosos ou pacientes com limita√ß√µes ao exerc√≠cio.
- [ ] 8. Solicitar 25(OH)D basal e repetir em ~2 meses; educar sobre metas 40‚Äì60 e tranquilizar quando n√≠veis estiverem entre 20‚Äì100, sem alarmismo com c√°lculo renal.
- [ ] 9. Iniciar vitamina D 2.000‚Äì10.000 UI/dia conforme n√≠vel basal; ajustar para manuten√ß√£o (2.000‚Äì5.000 UI; podendo 10.000‚Äì20.000 UI em alta demanda). Associar K2 (MK7 100‚Äì200 mcg) e ingerir com gordura.
- [ ] 10. Prescrever magn√©sio (glicina ou malato) em duas doses di√°rias, ajustando de 200‚Äì1.000 mg de magn√©sio elementar/dia conforme necessidade; considerar maior dose em inflama√ß√£o/estresse/hipertens√£o/transtornos ansiosos ou uso de altas doses de vitamina D.

---

### Chunk 15/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.519

iablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05‚Äì0.71)0.0060.45(0.01‚Äì0.86)0.015Physicalexercise(novs.high)0.97(0.44‚Äì3.13)0.941.07(0.24‚Äì2.51)0.69Milkconsumption(novs.high)1.39(0.57‚Äì3.34)0.466.32(1.04‚Äì38.29)0.045DHEA(ng/ml)0.75(0.61‚Äì1.05)0.060.73(0.51‚Äì0.96)0.032T20.89(0.63‚Äì1.24)0.620.78(0.44‚Äì2.22)0.72E20.67(0.33‚Äì2.65)0.580.90(0.46‚Äì3.12)0.65PTH(pg/ml)1.01(0.97‚Äì1.04)0.640.97(0.90‚Äì1.04)0.3625OHD(ng/ml)0.98(0.93‚Äì1.07)0.220.51(0.11‚Äì0.82)0.047CTX(pg/ml)1.02(0.98‚Äì1.05)0.171.02(0.92‚Äì1.12)0.78PINP(ng/ml)1.12(0.97‚Äì1.48)0.511.07(0.95‚Äì1.17)0.31Follistatin(ng/ml)1.08(0.56‚Äì2.09)0.171.66(1.19‚Äì3.57)0.022Myostatin(ng/ml)0.95(0.90‚Äì1.13)0.821.01(0.98‚Äì1.03)0.56BDNF(ng/ml)0.78(0.38‚Äì1.62)0.500.35(0.07‚Äì1.82)0.35Oxytocin(pg/ml)0.75(0.63‚Äì0.98)0.0190.88(0.57‚Äì1.01)0.14Multivariatelogisticanalysiswasperformedafteradjustingforage.DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagenc

---

### Chunk 16/30
**Article:** Mastologia II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.515

dos sintomas gerais a investigar em consulta, como dor mam√°ria e TPM intensa, que podem indicar predomin√¢ncia estrog√™nica.

## Objetivo:
N√£o h√° achados de exame f√≠sico de um paciente espec√≠fico. A abordagem objetiva descrita inclui:
- Avalia√ß√£o da composi√ß√£o corporal por bioimped√¢ncia ou densitometria de corpo total, identificando condi√ß√µes como sarcopenia em mulheres com peso normal.
- Solicita√ß√£o de exames laboratoriais para avaliar marcadores inflamat√≥rios e verificar se a paciente est√° metabolicamente doente ou em risco.

## Diagn√≥stico Prim√°rio:
- Avalia√ß√£o: Discuss√£o educacional sobre estratifica√ß√£o de risco para c√¢ncer de mama. 90% dos casos relacionam-se ao estilo de vida e 10% a fatores gen√©ticos conhecidos. Muta√ß√µes de alta penetr√¢ncia (ex.: BRCA1, BRCA2, TP53) aumentam significativamente o risco, por√©m s√£o raras. Epigen√©tica e estilo de vida s√£o cruciais e modific√°veis.

---

### Chunk 17/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.511

.140.24WHR(waist/hip)1.09¬±0.161.11¬±0.141.09¬±0.130.76Fatmass(kg)20.91¬±4.520.73¬±4.419.63¬±5.20.50Leanmass(kg)38.06¬±4.536.82¬±3.634.24v4.40.001ASMI(kg/m2)6.25¬±0.716.18¬±0.565.92¬±0.870.13LHLuteinizinghormone,FSHFolliclestimulatinghormone,DHEADehydroepiandrosterone,E2Estradiol,T2Testosterone,P1NPN-terminalpropeptideoftypeIcollagen,CTXCross-linkedC-telopeptideoftypeIcollagen,PTHParathyroidhormone,25OHDSerum25(OH)D,BDNFBrain-derivedneurotrophicfactor,BMIBodymassindex,BMDBonemineraldensity,WHRWaist/hipratio,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page5of10

inducedbylowmusclemassandfunction.However,highfollistatininhibitsmyostatin-mediatedmusclewast-ing[20].Wealsofoundthatmyostatinpositivelycorre-latedwithfatmass.Severallinesofevidencesuggestthatobesityposesathreattoskeletalmusclehealthviamyos-tatin[21].Extremelyobesewomensecreteandexpressincreasedamountsofmyostatininskeletalmuscle,whichcorrelatewithinsulinresistance[22].Theexpres-sionofmyostatindecr

---

### Chunk 18/30
**Article:** Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly (2020)
**Journal:** BMC Musculoskeletal Disorders
**Section:** abstract | **Similarity:** 0.510

Cross-sectional study of 120 elderly (‚â•65 years) showing sarcopenia patients had significantly lower IGF-1 (89.8 vs 118.6 ng/ml). Each 10 ng/ml IGF-1 increase reduced sarcopenia risk by 18%.

---

### Chunk 19/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.510

Bonemineraldensity,CTXC-telopeptidecollagencrosslinksDuetal.BMCGeriatrics         (2021) 21:542 Page6of10

fourgroupsofpostmenopausalwomenwithdifferentbonemusclestatusesandanalyzedtherelationshipsofbiomarkerswiththeriskofosteoporosisandsarcopenia.Theresultsshowedthatelevatedoxytocinlevelswereas-sociatedwithareducedriskofosteoporosis,andele-vatedDHEAlevelswereassociatedwithareducedriskofsarcopenia.However,elevatedfollistatinlevelswereassociatedwithanincreasedriskofsarcopenia.ThecurrentstudyfoundthatDHEAandoxytocinweresig-nificantlylowerinpostmenopausalwomenwithahis-toryoffragilityfracturecomparedtowomenwithoutfracture(datanotshown).Therefore,serumDHEAandfollistatinmaybebiomarkersofsarcopenia,andserumoxytocinmaybeabiomarkerofosteoporosis.Severalstudiesshowedthatphysicalexerciseinflu-encedserumlevelsoffollistatinandDHEA[33‚Äì35].Ourresultsshowedthatpostmenopausalwomenwith-outosteoporosis/sarcopeniaperformedhigherexerciselevelsthanwomenwithosteoporosis/sarcopenia.Fortheseresults,weconsider

---

### Chunk 20/30
**Article:** Fisiologia do Horm√¥nio do Crescimento Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.508

hormonais; poss√≠vel benef√≠cio de reposi√ß√£o de GH quando h√° defici√™ncia documentada.
## Objetivo:
- N√£o h√° dados objetivos de exame f√≠sico, resultados laboratoriais individuais, nem achados de imagem de um paciente espec√≠fico; conte√∫do √© educacional e de revis√£o.
- Revis√£o de estudos cl√≠nicos:
  - Homens jovens treinados: GH 0,04 mg/kg, 5 dias/semana, n√£o aumentou hipertrofia nem for√ßa com treino resistido.
  - Indiv√≠duos mais velhos: GH + treino n√£o aumentou s√≠ntese proteica; resultados semelhantes aos jovens.
  - GH isolado, em doses fisiol√≥gicas e suprafisiol√≥gicas (7‚Äì14 UI em alguns estudos), n√£o promoveu atividade anab√≥lica muscular significativa.
  - Aumento consistente de massa livre de gordura com GH, majoritariamente por reten√ß√£o h√≠drica (reabsor√ß√£o de s√≥dio tubular), sem ganho de for√ßa ou s√≠ntese miofibrilar.

---

### Chunk 21/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.505

osesathreattoskeletalmusclehealthviamyos-tatin[21].Extremelyobesewomensecreteandexpressincreasedamountsofmyostatininskeletalmuscle,whichcorrelatewithinsulinresistance[22].Theexpres-sionofmyostatindecreasedsignificantlydecreasedaftergastricsurgery,andinsulinresistancewassignificantlyimproved[23].Thisevidencesupportsthehypothesisthatobesityleadstoanincreaseinmyostatin,whichimpairsskeletalmusclehealth.Themainstrengthofthecurrentstudywasthatitsimultaneouslyconsideredtherelationshipbetweensev-eralbiomarkers,includingmyostatin,follistatin,oxyto-cin,BDNF,DHEA,T2andE2,andosteoporosisand/orsarcopeniainthesamestudypopulation.Therefore,thedegreeofcorrelationsbetweendifferentbiomarkersandboneandmusclewerecompared.Forthebiomarkersrelatedtosexhormones,ourstudyshowedthatDHEAwaspositivelyrelatedtohandgripandgaitspeed.Furtherresultsshowedthatpostmeno-pausalwomenwithsarcopeniaweremorelikelytohavehigherDHEAlevels.However,T2andE2werenotre-latedtomusclemass,gripstrengthorgaitspeed.Theseresultssuggestedthat

---

### Chunk 22/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.503

stratedthathistoryoffragilityfrac-ture(novs.fracture)(OR0.30;95%CI0.05‚Äì0.71;p=0.006)andoxytocin(OR0.75;95%CI0.63‚Äì0.98;p=0.019)wereassociatedwithosteoporosis,andhistoryoffragilityfracture(novs.fracture)(OR0.45;95%CI0.01‚Äì0.86;p=0.015),milkconsumption(novs.high)(OR6.32;95%CI1.04‚Äì38.29;p=0.045),DHEA(OR0.73;95%CI0.51‚Äì0.96;p=0.032),follistatin(OR1.66;95%CI1.19‚Äì3.57;p=0.022)and25OHD(OR0.51;95%CI0.11‚Äì0.82;p=0.047)wereassociatedwithsarcopenia(Table4).DiscussionsUsingcohortsofcommunity-dwellingpostmenopausalwomeninShanghai,China,weexaminedtherelation-shipbetween13circulatingbiomarkers,includingDHEA,E2,T2,LH,FSH,myostatin,follistatin,oxytocin,BDNF,CTX,PINP,PTHand25OHD,andbonemass,musclemass,strengthandfunctiontoevaluatetheprac-ticalvalueofthesebiomarkersinclinicalpractice.FollistatinpositivelycorrelatedwithLHandFSHandnegativelycorrelatedwithbonemass,musclemassandstrength.OurresultsshowedthatincreasedfollistatincoexistedwithreducedmusclestrengthandlowBMDinpatients,whichisconsistentwi

---

### Chunk 23/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.501

toexercisetrainingstatusandsex.Age(Dordr).2013;35(2):395‚Äì405.https://doi.org/10.1007/s11357-011-9345-y.36.Alem√°n-MateoH,Carre√≥nVR,Mac√≠asL,Astiazaran-Garc√≠aH,Gallegos-AguilarAC,Enr√≠quezJR.Nutrient-richdairyproteinsimproveappendicularskeletalmusclemassandphysicalperformance,andattenuatethelossofmusclestrengthinoldermenandwomensubjects:asingle-blindrandomizedclinicaltrial.ClinIntervAging.2014;9:1517‚Äì25.https://doi.org/10.2147/CIA.S67449.37.GranicA,HurstC,DismoreL,AsprayT,StevensonE,WithamM,etal.Milkforskeletalmusclehealthandsarcopeniainolderadults:anarrativereview.ClinIntervAging.2020;15:695‚Äì714.https://doi.org/10.2147/CIA.S245595.Publisher‚ÄôsNoteSpringerNatureremainsneutralwithregardtojurisdictionalclaimsinpublishedmapsandinstitutionalaffiliations.
Duetal.BMCGeriatrics         (2021) 21:542 Page10of10

---

### Chunk 24/30
**Article:** Bioqu√≠mica Metab√≥lica nos Exerc√≠cios - Parte III (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.501

a n√£o consensual; dose pr√°tica 1 g 3x/dia.
### 13. Hipertrofia: inflama√ß√£o e modula√ß√£o
- Hipertrofia depende de sobrecarga mec√¢nica, microles√µes, grande processo inflamat√≥rio e aumento de s√≠ntese proteica.
- IL-6, ERO e lactato s√£o sinaliza√ß√µes √∫teis; evitar anti-inflamat√≥rios/crioterapia e excesso de antioxidantes imediatamente ap√≥s.
- Demandas proteicas aumentam com VO2, intensidade e frequ√™ncia.
### 14. D√©ficit energ√©tico cr√¥nico e sinais cl√≠nicos
- Indicativos: am√¥nia, ureia, √°cido √∫rico, transaminases, cortisol altos; queda de performance e de massa; desidrata√ß√£o; pior recupera√ß√£o.
- Sinais: queda de cabelo, unhas quebradi√ßas, imunidade baixa; bioimped√¢ncia mostra altera√ß√µes de √°gua; poss√≠vel aumento de TSH e queda de T3 por d√©ficit energ√©tico (pseudo-hipotireoidismo).
- Hipertrofia invi√°vel sob catabolismo salvo interven√ß√µes hormonais n√£o-mTOR com resultados limitados.
### 15.

---

### Chunk 25/30
**Article:** Serum selenium and reduced mortality in middle-aged and older adults with prefrailty or frailty: the mediating role of inflammatory status (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.497

ors like 
infections or surgeries, leading to worse outcomes such as falls, 
hospitalization, and disability (
20
). ough commonly linked to 
aging, it can occur at any adult stage. While more prevalent in older 
adults, frailty aects 4¬ñ10% of middle-aged individuals (45¬ñ64 years), 
with higher rates seen in those with chronic disease, obesity, or lower 
socioeconomic status (
21
). On the other hand, proper nutrition has 
been shown to help reverse frailty by providing essential nutrients 
such as proteins, vitamins (D, B12), and minerals, all of which support 
muscle strength, bone health, and overall physical function (
22
, 
23
).
Current evidence suggests that selenium levels are closely 
associated with mortality risk across dierent populations. A meta-
analysis by Xiang etal. (
14
) found that low circulating selenium was 
linked to a higher risk of cardiovascular and all-cause mortality in the 
general population, with pooled risk ratios of 1.36 and 1.35, 
respectively.

---

### Chunk 26/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte XIX (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.497

al para prevenir complica√ß√µes.
*   **Estrat√©gias para Preservar Massa Magra no Emagrecimento**
    - A pr√°tica de exerc√≠cios resistidos √© fundamental para a manuten√ß√£o da massa magra.
    - A ingest√£o de prote√≠na deve ser superior √†s diretrizes atuais de 0,8 g/kg de peso corporal por dia. Para pacientes em tratamento para obesidade, a recomenda√ß√£o √© de mais de 1.5 g/kg de peso para evitar o catabolismo muscular, especialmente ao usar medicamentos que reduzem o apetite.
    - Se a meta proteica n√£o for atingida pela dieta, deve-se considerar a suplementa√ß√£o com whey protein ou shakes de prote√≠na.
*   **Abordagem Pr√©-Tratamento da Obesidade (Medicamentosa ou Cir√∫rgica)**
    - Antes de iniciar qualquer tratamento, √© essencial discutir o peso, os h√°bitos alimentares (snacks, refrigerantes), o uso de suplementos e avaliar as causas e complica√ß√µes da obesidade.

---

### Chunk 27/30
**Article:** Serum selenium and reduced mortality in middle-aged and older adults with prefrailty or frailty: the mediating role of inflammatory status (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.495

older adults and are associated with higher risks of falls, 
disability, hospitalization, and mortality (
1
). Moreover, previous 
studies in the US have shown that hospitalization costs for frail 
patients are more than twice those of non-frail patients (
2
). Frail 
patients undergoing the same surgical procedures incur 
significantly higher median surgery costs, with hospitalization 
expenses increasing by approximately 30% (
3
). As the global 
population continues to age, identifying modifiable factors 
that can reduce mortality risk and alleviate healthcare costs in 
these populations has become a priority in public health 
research (
4
).
Frailty and prefrailty in middle-aged and older adults result from 
cumulative physiological decline driven by biological aging, including 
chronic inammation, hormonal dysregulation, and mitochondrial 
dysfunction (
5
).

---

### Chunk 28/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.493

.4%forCTXandbelow2.6and4.1%forP1NP,below2.7and6.5%forPTH,andbelow7.8and10.7%for25(OH)D.StatisticsSPSSv23(SPSSInc.,Chicago,IL,USA)wasusedtoanalyzethedata.KolmogorovSmirnovmethodwasusedtotestthenormaldistributionofdata.Continuousvari-ableswereexpressedasthemeanswithstandarddevi-ation,medianwithinterquartilerange(25‚Äì75%),andclassificationvariableswereexpressedaspercentages.DifferencesbetweengroupswereanalyzedusingANOVA,Kruskal-WallisHtestorPearson‚Äôschi-squaredDuetal.BMCGeriatrics         (2021) 21:542 Page3of10

testforcontinuousandcategoricalvariables,respect-ively.AftertheresidualwastestedbyExplore,multivari-atelinearregressionmodelswereconstructedtoanalyzethecorrelationbetweendependentvariables,suchasgripstrength,gaitspeed,leanmass,fatmass,ASMI,bonemass,andindependentcontinuouspredictors,suchasserummyokines,sexhormones,andboneturnovermarkers.Associationsbetweenhistoryoffragilityfrac-ture,lifestyle,serumbiomarkersandosteoporosisandsarcopeniawereanalyzedusinglogisticregressionana-lys

---

### Chunk 29/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.492

edandtheshortphysicalperformancebat-tery(SPPB).Techniciansgenerallydecidewhetherthetestcanbecompletedandthecompletiontime,whichcreatesacertainbias.Third,osteoporosisandsarcopeniaarechronicdiseases,andnotallindividualsexhibitthesameratesofmuscleandboneloss.Therefore,corre-spondingindicatorstotrackprogressionovertimeortheresponsetointerventionsareimportantandneces-sary.Toovercometheshortageofcurrentlyavailabletechniquestoevaluatemuscleandbone,apoolofserumbiomarkerswasrecentlydevelopedbasedonthemo-lecularbiologicalmechanismsoftheirinvolvementinthepathogenesisofsarcopeniaandosteoporosis,suchasendocrinesystem,growthfactors,andmuscleproteinturnover.Biomarkers,whichtheoreticallyaffectthesemechanisms,maypredictorreflectthestateofbonesandmuscles[5,6].However,whetherthesebiomarkerstrulyreflectthestateofbonesandmuscleswasnotveri-fied.Toexploretherelationshipbetweenbiomarkersandbonesandmuscles,weidentifiedbiomarkersofosteoporosisandsarcopeniaaccordingtodifferentpathophysiologicalmechanisms.(1)Myok

---

### Chunk 30/30
**Article:** Abordagem Funcional Integrativa Aplicada a Cada √Årea - Parte IV (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.491

browning, sa√∫de √≥ssea e metab√≥lica; perda muscular acelerada prejudica desfechos e ades√£o; decl√≠nio por idade ~0,8%/ano torna-se preocupante quando agravado por f√°rmacos sem suporte.
- Nutri√ß√£o, saciedade e risco proteico
  - Descri√ß√£o: GLP-1 reduz fome e lentifica esvaziamento g√°strico, dificultando ingest√£o de prote√≠na (especialmente carnes), elevando risco de d√©ficit proteico e perda muscular; prescri√ß√£o sem orienta√ß√£o estrita de nutri√ß√£o e exerc√≠cio √© inaceit√°vel.
### 8. Tecido adiposo branco, inflama√ß√£o e lipossubstitui√ß√£o
- Descri√ß√£o: Excesso de adip√≥cito branco aumenta inflama√ß√£o de baixo grau, resist√™ncia insul√≠nica e disfun√ß√µes; perder m√∫sculo e reganhar gordura promove lipossubstitui√ß√£o e piora sist√™mica.
### 9.

---

